Expression of NLRP3 inflammatory body in a rat model of liver fibrosis induced by common bile duct ligation

Meng'en ZHOU; Yirong CHEN; Na ZHANG; Ni YAN; Renye QUE; Yong LI

doi:10.3969/j.issn.1001-5256.2021.09.020

Volume 37 Issue 9

Sep. 2021

Turn off MathJax

Article Contents

Article Navigation > Journal of Clinical Hepatology > 2021 > 37(9): 2102-2108

PDF( 7845 KB)

Expression of NLRP3 inflammatory body in a rat model of liver fibrosis induced by common bile duct ligation

DOI: 10.3969/j.issn.1001-5256.2021.09.020

Department of Gastroenterology, Shanghai Municipal Hospital of Traditional Chinese Medicine Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200071, China

Research funding:

National Natural Science Foundation of China (81573775);

National Natural Science Foundation of China (81873157)

Received Date: 2021-02-18
Accepted Date: 2021-03-15
Published Date: 2021-09-20

Abstract

Abstract

Objective To investigate the expression of NLRP3 inflammatory body in the process of liver fibrosis in a rat model of common bile duct ligation (BDL) and the association of NLRP3 inflammatory body with liver fibrosis. Methods A total of 65 Sprague-Dawley rats were randomly divided into sham-operation group with 15 rats and BDL model group with 50 rats. On days 3, 7, 14, 21, and 28, 10 rats in the model group and 3 rats in the sham-operation group were sacrificed. The serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), direct bilirubin (DBil), total bilirubin (TBil), total bile acid (TBA), and alkaline phosphatase (ALP) were measured, and HE staining, Masson staining, and sirius red-picric acid staining were performed for liver tissue to evaluate liver fibrosis degree. Immunohistochemistry was used to measure the expression levels of alpha-smooth muscle actin (α-SMA) and transforming growth factor-β1 (TGF-β1) in liver tissue, Western blot and qRT-PCR were used to measure the expression level of NLRP3 inflammatory body, and ELISA was used to measure the level of the inflammatory factor interleukin-1β (IL-1β) in liver tissue. An analysis of variance was used for comparison of continuous data between groups, and the least significant difference t-test was used for further comparison between two groups. Results Compared with the sham-operation group, the BDL model group had significant increases in the serum levels of ALT, AST, DBil, TBil, TBA, and ALP (all P < 0.05) and the level of IL-1β in liver tissue (P < 0.05), which reached the highest level on day 3 and then decreased. Compared with the sham-operation group over time, the BDL group had a significant increase in liver fibrosis score (P < 0.05); immunohistochemistry showed gradual increases in the expression of SMA-α and TGF-β1 (P < 0.05), and Western blot and qRT-PCR showed a gradual increase in the protein expression of NLRP3 inflammatory body in liver tissue (P < 0.05), which remained stable after day 14. Conclusion Liver injury exists persistently in a rat model of BDL, and liver histopathology shows the dynamic evolution of hepatitis, liver fibrosis, and liver cirrhosis. NLRP3 inflammatory body is in a state of continuous activation and may play an important role in the process of liver fibrosis.
- Liver Cirrhosis,
- Cholestasis,
- NLR Family, Pyrin Domain-Containing 3 Protein,
- Rats, Sprague-Dawley

FullText(HTML)

References(28)

References

[1]	DU QH, ZHANG CJ, LI WH, et al. Gan Shen Fu Fang ameliorates liver fibrosis in vitro and in vivo by inhibiting the inflammatory response and extracellular signal-regulated kinase phosphorylation[J]. World J Gastroenterol, 2020, 26(21): 2810-2820. DOI: 10.3748/wjg.v26.i21.2810.
[2]	TRAUTWEIN C, FRIEDMAN SL, SCHUPPAN D, et al. Hepatic fibrosis: Concept to treatment[J]. J Hepatol, 2015, 62(1 Suppl): s15-s24. DOI: 10.1016/j.jhep.2015.02.039.
[3]	WU X, DONG L, LIN X, et al. Relevance of the NLRP3 inflammasome in the pathogenesis of chronic liver disease[J]. Front Immunol, 2017, 8: 1728. DOI: 10.3389/fimmu.2017.01728.
[4]	HE K, ZHU X, LIU Y, et al. Inhibition of NLRP3 inflammasome by thioredoxin-interacting protein in mouse Kupffer cells as a regulatory mechanism for non-alcoholic fatty liver disease development[J]. Oncotarget, 2017, 8(23): 37657-37672. DOI: 10.18632/oncotarget.17489.
[5]	CUI K, YAN G, XU C, et al. Invariant NKT cells promote alcohol-induced steatohepatitis through interleukin-1β in mice[J]. J Hepatol, 2015, 62(6): 1311-1318. DOI: 10.1016/j.jhep.2014.12.027.
[6]	WU X, ZHANG F, XIONG X, et al. Tetramethylpyrazine reduces inflammation in liver fibrosis and inhibits inflammatory cytokine expression in hepatic stellate cells by modulating NLRP3 inflammasome pathway[J]. IUBMB Life, 2015, 67(4): 312-321. DOI: 10.1002/iub.1348.
[7]	LENTSCH AB, KATO A, YOSHIDOME H, et al. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury[J]. Hepatology, 2000, 32(2): 169-173. DOI: 10.1053/jhep.2000.9323.
[8]	SHARAWY MH, ABDEL-RAHMAN N, MEGAHED N, et al. Paclitaxel alleviates liver fibrosis induced by bile duct ligation in rats: Role of TGFβ1, IL-10 and c-Myc[J]. Life Sci, 2018, 211: 245-251. DOI: 10.1016/j.lfs.2018.09.037.
[9]	Chinese Society of Hepatology, Chinese Medical Association; Chinese Society of Gastroenterology, Chinese Medical Association; Chinese Society of Infectious Diseases, Chinese Medical Association. Consensus on the diagnosis and therapy of hepatic fibrosis(2019)[J]. J Clin Hepatol, 2019, 35(10): 2163-2172. DOI: 10.3969/j.issn.1001-5256.2019.10.007. 中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会感染病学分会. 肝纤维化诊断及治疗共识(2019年)[J]. 临床肝胆病杂志, 2019, 35(10): 2163-2172. DOI: 10.3969/j.issn.1001-5256.2019.10.007.
[10]	TAG CG, SAUER-LEHNEN S, WEISKIRCHEN S, et al. Bile duct ligation in mice: Induction of inflammatory liver injury and fibrosis by obstructive cholestasis[J]. J Vis Exp, 2015, 96: 52438. DOI: 10.3791/52438.
[11]	ELPEK GÖ. Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update[J]. World J Gastroenterol, 2014, 20(23): 7260-7276. DOI: 10.3748/wjg.v20.i23.7260.
[12]	ZHOU WC, ZHANG QB, QIAO L. Pathogenesis of liver cirrhosis[J]. World J Gastroenterol, 2014, 20(23): 7312-7324. DOI: 10.3748/wjg.v20.i23.7312.
[13]	CHANG J, LAN T, LI C, et al. Activation of Slit2-Robo1 signaling promotes liver fibrosis[J]. J Hepatol, 2015, 63(6): 1413-1420. DOI: 10.1016/j.jhep.2015.07.033.
[14]	YANG F, LI LH. Effect of vitamin D receptor activation on hepatic fibrosis induced by bile duct ligation in mice and its mechanism[J]. J Jilin Univ(Med Edit), 2020, 46(4): 722-727. DOI: 10.13481/j.1671-587x.20200409. 杨帆, 李丽华. 维生素D受体激活对小鼠胆管结扎所致肝纤维化的影响及其机制[J]. 吉林大学学报(医学版), 2020, 46(4): 722-727. DOI: 10.13481/j.1671-587x.20200409.
[15]	WU N, MENG F, ZHOU T, et al. The secretin/secretin receptor axis modulates ductular reaction and liver fibrosis through changes in transforming growth factor-β1-mediated biliary senescence[J]. Am J Pathol, 2018, 188(10): 2264-2280. DOI: 10.1016/j.ajpath.2018.06.015.
[16]	GRESSNER AM, WEISKIRCHEN R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets[J]. J Cell Mol Med, 2006, 10(1): 76-99. DOI: 10.1111/j.1582-4934.2006.tb00292.x.
[17]	CAO Z, WANG Y, LONG Z, et al. Interaction between autophagy and the NLRP3 inflammasome[J]. Acta Biochim Biophys Sin (Shanghai), 2019, 51(11): 1087-1095. DOI: 10.1093/abbs/gmz098.
[18]	GROSLAMBERT M, PY BF. Spotlight on the NLRP3 inflammasome pathway[J]. J Inflamm Res, 2018, 11: 359-374. DOI: 10.2147/JIR.S141220.
[19]	LAMKANFI M, DIXIT VM. Mechanisms and functions of inflammasomes[J]. Cell, 2014, 157(5): 1013-1022. DOI: 10.1016/j.cell.2014.04.007.
[20]	STROWIG T, HENAO-MEJIA J, ELINAV E, et al. Inflammasomes in health and disease[J]. Nature, 2012, 481(7381): 278-286. DOI: 10.1038/nature10759.
[21]	INZAUGARAT ME, JOHNSON CD, HOLTMANN TM, et al. NLR family pyrin domain-containing 3 inflammasome activation in hepatic stellate cells induces liver fibrosis in mice[J]. Hepatology, 2019, 69(2): 845-859. DOI: 10.1002/hep.30252.
[22]	WANG H, LV C, WANG S, et al. NLRP3 Inflammasome involves in the acute exacerbation of patients with chronic obstructive pulmonary disease[J]. Inflammation, 2018, 41(4): 1321-1333. DOI: 10.1007/s10753-018-0780-0.
[23]	WADA J, MAKINO H. Innate immunity in diabetes and diabetic nephropathy[J]. Nat Rev Nephrol, 2016, 12(1): 13-26. DOI: 10.1038/nrneph.2015.175.
[24]	LIU D, ZENG X, LI X, et al. Role of NLRP3 inflammasome in the pathogenesis of cardiovascular diseases[J]. Basic Res Cardiol, 2018, 113(1): 5. DOI: 10.1007/s00395-017-0663-9.
[25]	ZHEN Y, ZHANG H. NLRP3 Inflammasome and inflammatory bowel disease[J]. Front Immunol, 2019, 10: 276. DOI: 10.3389/fimmu.2019.00276.
[26]	ZHANG N, YAN N, ZHOU ME, et al. Development and treatment of NLRP3 inflammatory corpuscule in acute and chronic liver diseases[J]. Liaoning J Trad Chin Med, 2020, 47(5): 217-220. DOI: 10.13192/j.issn.1000-1719.2020.05.065. 张娜, 晏旎, 周蒙恩, 等. NLRP3炎症小体在急慢性肝脏疾病发生和治疗中的研究进展[J]. 辽宁中医杂志, 2020, 47(5): 217-220. DOI: 10.13192/j.issn.1000-1719.2020.05.065.
[27]	MRIDHA AR, WREE A, ROBERTSON A, et al. NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice[J]. J Hepatol, 2017, 66(5): 1037-1046. DOI: 10.1016/j.jhep.2017.01.022.
[28]	GONG Z, ZHOU J, ZHAO S, et al. Chenodeoxycholic acid activates NLRP3 inflammasome and contributes to cholestatic liver fibrosis[J]. Oncotarget, 2016, 7(51): 83951-83963. DOI: 10.18632/oncotarget.13796.

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(6) / Tables(5)

Get Citation

PDF

XML

Article Metrics

Article views (599) PDF downloads(33)

Expression of NLRP3 inflammatory body in a rat model of liver fibrosis induced by common bile duct ligation

DOI: 10.3969/j.issn.1001-5256.2021.09.020

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Expression of NLRP3 inflammatory body in a rat model of liver fibrosis induced by common bile duct ligation

DOI: 10.3969/j.issn.1001-5256.2021.09.020

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content